Metabolic syndrome and atrial fibrillation in patients with essential hypertension

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 2, 2013, Pages 109-114

  Vyssoulis, G ^a   Karpanou, E ^b   Adamopoulos, D ^a   Kyvelou, S M ^a   Tzamou, V ^a   Michaelidis, A ^a   Stefanadis, C ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Atrial fibrillation; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873429246     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.03.011     Document Type: Article

References (26)

1. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
2. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98:946-952.
3. Stewart S., Hart C.L., Hole D.J., McMurray J.J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002, 113:359-364.
4. Movahed M.R., Hashemzadeh M., Jamal M.M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005, 105:315-318.
5. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
6. Wang T.J., Parise H., Levy D., D'Agostino R.B., Wolf P.A., Vasan R.S., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292:2471-2477.
7. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
8. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
9. Hu R., Ma C.S., Nie S.P., Lu Q., Kang J.P., Du X., et al. Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease. Chin Med J (Engl) 2006, 119:1871-1876.
10. Korantzopoulos P., Kokkoris S., Papaioannides D. The association of metabolic syndrome with atrial fibrillation: an emerging epidemiological and pathophysiological hypothesis. Cardiology 2005, 104:148-149.
11. Watanabe H., Tanabe N., Watanabe T., Darbar D., Roden D.M., Sasaki S., et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008, 117:1255-1260.
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
13. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
14. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
15. Macchia A., Levantesi G., Borrelli G., Franzosi M.G., Maggioni A.P., Marfisi R., et al. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J 2006, 151:754.
16. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001, 285:2370-2375.
17. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449-1457.
18. Conen D., Tedrow U.B., Cook N.R., Moorthy M.V., Buring J.E., Albert C.M. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008, 300:2489-2496.
19. Dublin S., French B., Glazer N.L., Wiggins K.L., Lumley T., Psaty B.M., et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006, 166:2322-2328.
20. Markides V., Schilling R.J. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 2003, 89:939-943.
21. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: The Framingham Heart Study. Circulation 1994, 89:724-730.
22. Messerli F.H., Ventura H.O., Reisin E., Dreslinski G.R., Dunn F.G., MacPhee A.A., et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 1982, 66:55-60.
23. Iacobellis G., Ribaudo M.C., Leto G., Zappaterreno A., Vecci E., Di Mario U., et al. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 2002, 10:767-773.
24. Engeli S., Sharma A.M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 2001, 79:21-29.
25. Vincent H.K., Powers S.K., Stewart D.J., Shanely R.A., Demirel H., Naito H. Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord 1999, 23:67-74.
26. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Lee E.T., Welty T.K., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000, 101:2271-2276.